Affan A Ansari

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Oxidative Stress

Endoplasmic Reticulum

Estrogen Receptor

Papillary Thyroid

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Snigdha Banerjee, Affan A Ansari, Sunil P Upadhyay, Daniel J Mettman, Jamie R Hibdon, Mohiuddin Quadir, Pratyusha Ghosh, Anjali Kambhampati, Sushanta K Banerjee
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers. Cells 13 (5) (2024)
Snigdha Banerjee, Affan A Ansari, Sunil P Upadhyay, Daniel J Mettman, Jamie R Hibdon, Mohiuddin Quadir, Pratyusha Ghosh, Anjali Kambhampati, Sushanta K Banerjee
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers. Cells 13 (5) (2024)
Snigdha Banerjee, Affan A Ansari, Sunil P Upadhyay, Daniel J Mettman, Jamie R Hibdon, Mohiuddin Quadir, Pratyusha Ghosh, Anjali Kambhampati, Sushanta K Banerjee
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers. Cells 13 (5) (2024)
Snigdha Banerjee, Affan A Ansari, Sunil P Upadhyay, Daniel J Mettman, Jamie R Hibdon, Mohiuddin Quadir, Pratyusha Ghosh, Anjali Kambhampati, Sushanta K Banerjee
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers. Cells 13 (5) (2024)
Snigdha Banerjee, Affan A Ansari, Sunil P Upadhyay, Daniel J Mettman, Jamie R Hibdon, Mohiuddin Quadir, Pratyusha Ghosh, Anjali Kambhampati, Sushanta K Banerjee
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers. Cells 13 (5) (2024)